Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bluebird Bio (BLUE)

Bluebird Bio (BLUE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,424,652
  • Shares Outstanding, K 55,331
  • Annual Sales, $ 54,580 K
  • Annual Income, $ -555,630 K
  • 60-Month Beta 2.37
  • Price/Sales 100.07
  • Price/Cash Flow N/A
  • Price/Book 3.66

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -3.79
  • Number of Estimates 12
  • High Estimate -3.02
  • Low Estimate -4.11
  • Prior Year -2.72
  • Growth Rate Est. (year over year) -39.34%

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.26 +16.35%
on 01/03/20
99.36 -1.33%
on 01/17/20
+2.88 (+3.03%)
since 12/17/19
3-Month
71.42 +37.27%
on 11/22/19
99.36 -1.33%
on 01/17/20
+6.71 (+7.35%)
since 10/17/19
52-Week
71.42 +37.27%
on 11/22/19
163.43 -40.01%
on 04/03/19
-28.46 (-22.50%)
since 01/17/19

Most Recent Stories

More News
bluebird bio Announces Launch in Germany of ZYNTEGLO(TM) (autologous CD34+ cells encoding BA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent B-Thalassemia Who Do Not Have B(0)/B(0)Genotype

--First qualified treatment center established at University Hospital of Heidelberg to provide ZYNTEGLO to patients

BLUE : 98.04 (+0.58%)
SmarTrend Watching for Potential Pullback in Shares of Bluebird Bio Inc After 2.99% Gain

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $91.00 to a high of $94.12. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high...

BLUE : 98.04 (+0.58%)
Bluebird Bio (BLUE) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Bluebird Bio (BLUE) closed at $91.77, marking a +1.75% move from the previous day.

BLUE : 98.04 (+0.58%)
Bluebird Bio Inc Shares Up 7.6% Since SmarTrend's Buy Recommendation (BLUE)

SmarTrend identified an Uptrend for Bluebird Bio Inc (NASDAQ:BLUE) on November 29th, 2019 at $82.48. In approximately 1 month, Bluebird Bio Inc has returned 7.60% as of today's recent price of $88.74....

BLUE : 98.04 (+0.58%)
Novo Nordisk's Shares Up in a Year on Pipeline Progress

Novo Nordisk's (NVO) shares have gained in the past year as it makes significant progress in pipeline development.

NVO : 61.31 (unch)
MRK : 90.97 (-0.23%)
GILD : 62.98 (-0.35%)
BLUE : 98.04 (+0.58%)
Relatively Good Performance Detected in Shares of Myriad Genetics in the Biotechnology Industry (MYGN , XON , BLUE , ATRA , MNTA )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

BLUE : 98.04 (+0.58%)
XON : 5.83 (-6.12%)
MYGN : 28.72 (-0.69%)
Bluebird Bio Inc Set to Possibly Pullback After Yesterday's Rally of 2.38%

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $89.33 to a high of $92.16. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high...

BLUE : 98.04 (+0.58%)
bluebird bio Announces Investor Events in January

bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will present at the following upcoming investor conferences in January:

JPM : 138.20 (+0.69%)
BLUE : 98.04 (+0.58%)
Bluebird Bio Inc Rises 3.11% on Heavy Volume: Watch For Potential Pullback

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $91.76 to a high of $95.57. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high...

BLUE : 98.04 (+0.58%)
bluebird (BLUE) Catches Eye: Stock Jumps 6.8%

bluebird (BLUE) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

BLUE : 98.04 (+0.58%)
ANIK : 45.43 (-3.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade BLUE with:

Business Summary

Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio,...

See More

Key Turning Points

2nd Resistance Point 100.57
1st Resistance Point 99.30
Last Price 98.04
1st Support Level 96.83
2nd Support Level 95.63

See More

52-Week High 163.43
Fibonacci 61.8% 128.28
Fibonacci 50% 117.42
Fibonacci 38.2% 106.57
Last Price 98.04
52-Week Low 71.42

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar